Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder

Objective: This study examines the outcome of augmentation cystoplasty (AC) in children with stages III and IV chronic kidney disease (CKD) secondary to neurogenic bladder in which transplantation was not imminent. Methods: Hospital records of all children with CKD stages III and IV who underwent AC...

Full description

Bibliographic Details
Main Authors: Sanjay Sinha, Mehul Shah
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Asian Journal of Urology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214388221000473
_version_ 1811339276493783040
author Sanjay Sinha
Mehul Shah
author_facet Sanjay Sinha
Mehul Shah
author_sort Sanjay Sinha
collection DOAJ
description Objective: This study examines the outcome of augmentation cystoplasty (AC) in children with stages III and IV chronic kidney disease (CKD) secondary to neurogenic bladder in which transplantation was not imminent. Methods: Hospital records of all children with CKD stages III and IV who underwent AC between 2008 and 2017 were retrieved to study outcome and complications including estimated glomerular filtration rate (eGFR, National Kidney Foundation Calculator), somatic growth (percentiles, compared with population data), and febrile urinary tract infections (fUTIs) requiring admission. Statistical analysis was performed using R. Results: AC was performed in 13 children with CKD stages III and IV (10 girls; median 8.0 years) with median follow-up of 51 months. Patients had incontinence (10/13), reflux (7/13), and hydronephrosis (13/13) despite antimuscarinics and intermittent catheterization. Bladder capacity was 74% of expected and median compliance was 5 mL/cm H20 (inter-quartile range 4 mL/cm H20). All underwent ileocystoplasty (25 cm bowel). One each had nephrectomy and mitrofanoff conduit. All had resolution of incontinence. One had acute kidney injury that recovered. Initial eGFR at presentation (24 mL/min/1.73 m2) improved with conservative management alone (52 mL/min/1.73 m2, p=0.004). This improved further 1 year following AC (61 mL/min/1.73 m2, p=0.036) with stable function at 7 years. There was improvement in somatic growth, hydronephrosis, and fUTI despite no ureteric re-implantation. Conclusion: AC carries acceptable morbidity in children with CKD stages III and IV secondary to neurogenic bladder. Surgery is effective with improvements in continence, eGFR, somatic growth, and propensity for fUTIs. Ureteric re-implantation might not be necessary.
first_indexed 2024-04-13T18:23:59Z
format Article
id doaj.art-dd49ce88065b40b7aa4f432093b628be
institution Directory Open Access Journal
issn 2214-3882
language English
last_indexed 2024-04-13T18:23:59Z
publishDate 2022-07-01
publisher Elsevier
record_format Article
series Asian Journal of Urology
spelling doaj.art-dd49ce88065b40b7aa4f432093b628be2022-12-22T02:35:19ZengElsevierAsian Journal of Urology2214-38822022-07-0193313317Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladderSanjay Sinha0Mehul Shah1Department of Urology, Apollo Hospitals, Hyderabad, India; Department of Nephrology, Apollo Hospitals, Hyderabad, India; Corresponding author. Departments of Urology, Apollo Hospitals, Hyderabad, India.Department of Urology, Apollo Hospitals, Hyderabad, India; Department of Nephrology, Apollo Hospitals, Hyderabad, IndiaObjective: This study examines the outcome of augmentation cystoplasty (AC) in children with stages III and IV chronic kidney disease (CKD) secondary to neurogenic bladder in which transplantation was not imminent. Methods: Hospital records of all children with CKD stages III and IV who underwent AC between 2008 and 2017 were retrieved to study outcome and complications including estimated glomerular filtration rate (eGFR, National Kidney Foundation Calculator), somatic growth (percentiles, compared with population data), and febrile urinary tract infections (fUTIs) requiring admission. Statistical analysis was performed using R. Results: AC was performed in 13 children with CKD stages III and IV (10 girls; median 8.0 years) with median follow-up of 51 months. Patients had incontinence (10/13), reflux (7/13), and hydronephrosis (13/13) despite antimuscarinics and intermittent catheterization. Bladder capacity was 74% of expected and median compliance was 5 mL/cm H20 (inter-quartile range 4 mL/cm H20). All underwent ileocystoplasty (25 cm bowel). One each had nephrectomy and mitrofanoff conduit. All had resolution of incontinence. One had acute kidney injury that recovered. Initial eGFR at presentation (24 mL/min/1.73 m2) improved with conservative management alone (52 mL/min/1.73 m2, p=0.004). This improved further 1 year following AC (61 mL/min/1.73 m2, p=0.036) with stable function at 7 years. There was improvement in somatic growth, hydronephrosis, and fUTI despite no ureteric re-implantation. Conclusion: AC carries acceptable morbidity in children with CKD stages III and IV secondary to neurogenic bladder. Surgery is effective with improvements in continence, eGFR, somatic growth, and propensity for fUTIs. Ureteric re-implantation might not be necessary.http://www.sciencedirect.com/science/article/pii/S2214388221000473Neurogenic bladderChronic kidney diseaseAugmentation cystoplastyVesicoureteric refluxUrodynamics
spellingShingle Sanjay Sinha
Mehul Shah
Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
Asian Journal of Urology
Neurogenic bladder
Chronic kidney disease
Augmentation cystoplasty
Vesicoureteric reflux
Urodynamics
title Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
title_full Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
title_fullStr Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
title_full_unstemmed Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
title_short Augmentation cystoplasty in children with stages III and IV chronic kidney disease secondary to neurogenic bladder
title_sort augmentation cystoplasty in children with stages iii and iv chronic kidney disease secondary to neurogenic bladder
topic Neurogenic bladder
Chronic kidney disease
Augmentation cystoplasty
Vesicoureteric reflux
Urodynamics
url http://www.sciencedirect.com/science/article/pii/S2214388221000473
work_keys_str_mv AT sanjaysinha augmentationcystoplastyinchildrenwithstagesiiiandivchronickidneydiseasesecondarytoneurogenicbladder
AT mehulshah augmentationcystoplastyinchildrenwithstagesiiiandivchronickidneydiseasesecondarytoneurogenicbladder